Page last updated: 2024-11-13
doxycycline hyclate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
Tetraclean: antibiotic-based product for root canal irrigation to remove both the microorganisms and the smear layer present in the root canals; contains cetrimide (Cetrimonium Compounds) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 54686183 |
CHEMBL ID | 3989740 |
MeSH ID | M0104501 |
Synonyms (87)
Synonym |
---|
vibravenos |
tetradox |
azudoxat |
spanor |
retens |
mespafin |
ronaxan |
lymepak (tn) |
doxy |
periostat (tn) |
vibra-tabs (tn) |
D02129 |
doryx (tn) |
doxycycline hydrochloride hydrate (jp17) |
doxycycline hyclate (usp) |
doxy 100 |
atridox |
doxy-lemmon |
6-deoxy-5-hydroxytetracycline hydrochloride hemihydrate |
doxy 200 |
vivox |
vibra-tabs |
periostat |
4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate |
doryx |
doxychel hyclate |
doxycycline hyclate (internal use) |
(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide - ethanol (2:1) dihydrochloride hydrate |
AC-6017 |
nsc-741421 |
S4163 |
nsc 741421 |
doryx mpc |
tetraclean |
dentista |
doxycycline hyclate [usan:usp] |
unii-19xts3t51u |
acticlate |
wc 2031 |
19xts3t51u , |
doxteric |
acticlate cap |
monodoks |
doxyprex |
doxycycline hyclate [ep impurity] |
doxycyclini hyclas [who-ip latin] |
doxycycline hyclate [ep monograph] |
lymepak |
doxycycline hyclate [usp-rs] |
doxycycline hydrochloride hemiethanolate hemihydrate [mi] |
doxycycline hyclate [usp monograph] |
unacil |
doxycycline hyclate [who-ip] |
vibraveineuse |
doxycycline hyclate [vandf] |
doxicrisol |
duradoxal |
doxycycline hydrochloride hydrate [jan] |
zadorin |
doxylar |
granudoxy |
doxycycline hyclate [who-dd] |
doxycycline hyclate [orange book] |
doxycycline hyclate [green book] |
diocimex |
clinofug |
AKOS025402170 |
(4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride |
wc2031 |
EN300-379220 |
bis((4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide) ethanol hydrate dihydrochloride |
Z2791720087 |
(4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide compound with ethanol (2:1) dihydrochloride hydrate |
CHEMBL3989740 |
doxycyclini hyclas |
doxycycline hydrochloride hydrate |
SW219440-2 |
SW219440-1 |
DS-9077 |
doxycycline, hyclate - cas 24390-14-5 |
Q27116248 |
doxycycline hyclate 100 microg/ml in acetonitrile |
AMY32700 |
CCG-270611 |
doxycycline hyclate is known as a broad-spectrum tetracycline antibiotic. |
BD166236 |
AKOS040742632 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 8 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 126.79
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (126.79) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 3 (25.00%) | 5.53% |
Reviews | 2 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (58.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |